Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
Acquisition of exclusive commercialization rights for European markets
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
The plant will drive pharmaceutical innovation in the Northeastern India
Subscribe To Our Newsletter & Stay Updated